[{"Assets_0_Q1_USD":"811651000.0","CIK":"1628171","CommonStockSharesIssued_0_Q1_shares":"73435109.0","CommonStockSharesOutstanding_0_Q1_shares":"73435109.0","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"-0.53","Industry":"Specialty Chemicals","Market":"NASDAQ","Market Cap":"1775342076.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"-37246000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":"-37176000.0","NetIncomeLoss_1_Q1_USD":"-37176000.0","OfficialName":"Revolution Medicines Inc. Common Stock","ProfitLoss_1_Q1_USD":"-37176000.0","RevenuesConverted_1_Q1_USD":"10131000.0","SP500":null,"Sector":"Consumer Durables","StockholdersEquity_0_Q1_USD":"722580000.0","Ticker":"RVMD","WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":"70420076.0","filed":"20210510","footnote":null,"form":"10-Q","fp":"Q1","fy":"2021.0","name":"REVOLUTION MEDICINES, INC.","period":"20210331","qtrs":"1","uom":"USD"}]